FDA proposes randomized, controlled testing for incontinence devices

10/5/2008 | FDAnews

The easiest way to obtain data on the safety and effectiveness of urinary incontinence devices is to conduct randomized, controlled clinical studies, according to an FDA draft guidance. Such trials can help overcome major issues in testing the products, including the diversity of the general patient population. The agency will accept comments on the draft until Dec. 18.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN